|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61K 31/513 | |||
| A61K 31/655 | |||
| A61K 31/7072 | |||
| A61K 31/7088 | |||
| A61P 35/00 | |||
| C07K 14/71 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2793925 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12809999.1 |
| Europos patento paraiškos padavimo data | 2012-12-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/070571 |
| Data | 2012-12-19 |
| (87) | Numeris | WO 2013/106175 |
| Data | 2013-07-18 |
| (30) | Numeris | Data | Šalis |
| 201113329897 | 2011-12-19 | US |
| (72) |
SUN, Jeonghoon, US
TAM, Lei-Ting Tony, US
HAN, Huiquan, US
KWAK, Keith Soo-Nyung, US
ZHOU, Xiaolan, US
LU, John, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320,
US
|
| (54) | VARIANT ACTIVIN RECEPTOR POLYPEPTIDES, ALONE OR IN COMBINATION WITH CHEMOTHERAPY, AND USES THEREOF |
| VARIANT ACTIVIN RECEPTOR POLYPEPTIDES, ALONE OR IN COMBINATION WITH CHEMOTHERAPY, AND USES THEREOF |